Acura Pharmaceuticals Inc (ACUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2005 | 06-2005 | 03-2005 | 12-2004 | 09-2004 | |
| Cost of Goods | N/A | N/A | N/A | -2 | N/A |
| Gross Profit | N/A | N/A | N/A | 2 | N/A |
| Operating Expenses | 1,473 | 1,266 | 1,908 | -39,856 | 51,646 |
| Operating Income | -1,473 | -1,266 | -1,908 | 39,856 | -51,646 |
| Interest Expense | 171 | 137 | 126 | 123 | 687 |
| Other Income | 9 | 21 | 86 | -41,817 | 853 |
| Pre-tax Income | -1,635 | -1,382 | -1,948 | -2,084 | -51,480 |
| Net Income Continuous | -1,635 | -1,382 | -1,948 | -2,084 | -51,480 |
| Net Income | $-1,635 | $-1,382 | $-1,948 | $-2,084 | $-51,480 |
| EPS Basic Total Ops | -3.50 | -3.00 | -4.50 | -4.50 | -117.50 |
| EPS Basic Continuous Ops | -3.53 | -3.01 | -4.36 | -4.71 | -117.38 |
| EPS Diluted Total Ops | -3.50 | -3.00 | -4.50 | -3.00 | -117.50 |
| EPS Diluted Continuous Ops | -3.53 | -3.01 | -4.36 | -3.26 | -117.38 |
| EBITDA(a) | $-1,442 | $-1,232 | $-1,876 | $39,825 | $-45,745 |